Imiquimod as an antiaging agent.

[1]  A. Gaspari,et al.  Toll-like receptors: applications to dermatologic disease. , 2006, Journal of the American Academy of Dermatology.

[2]  E. Lain,et al.  Imiquimod treatment of exuberant granulation tissue in a nonhealing diabetic ulcer. , 2005, Archives of dermatology.

[3]  Katherine E. Talcott,et al.  Imiquimod as an antiangiogenic agent. , 2005, Journal of drugs in dermatology : JDD.

[4]  A. Veyre,et al.  In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases , 2004, The British journal of dermatology.

[5]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[6]  R. Kuwahara,et al.  Treatment of lentigo maligna with topical imiquimod , 2003, The British journal of dermatology.

[7]  James Varani,et al.  Mechanisms of photoaging and chronological skin aging. , 2002, Archives of dermatology.

[8]  M. Eller,et al.  Mechanisms of aging. , 2002, Archives of dermatology.

[9]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.